Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Sep 29;24(1):588.
doi: 10.1186/s13054-020-03307-5.

No time for pending confirmation of invasive fungal disease in critically ill COVID-19 patients-think empirical treatment

Anne-Lise Bienvenu  1   2 , Nathalie Bleyzac  3 , Jean-Christophe Richard  4 , Gilles Leboucher  3
Affiliations
Comment

No time for pending confirmation of invasive fungal disease in critically ill COVID-19 patients-think empirical treatment

Anne-Lise Bienvenu et al. Crit Care. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Comment on

References

    1. Wang J, Yang Q, Zhang P, Sheng J, Zhou J, Qu T. Clinical characteristics of invasive pulmonary aspergillosis in patients with COVID-19 in Zhejiang, China: a retrospective case series. Crit Care. 2020;24:299. doi: 10.1186/s13054-020-03046-7. - DOI - PMC - PubMed
    1. Bartoletti M, Pascale R, Cricca M, Rinaldi M, Maccaro A, Bussini L, et al. Epidemiology of invasive pulmonary aspergillosis among COVID-19 intubated patients: a prospective study. Clin Infect Dis. 2020. 10.1093/cid/ciaa1065. - PMC - PubMed
    1. Brüggemann RJ, van de Veerdonk FL, Verweij PE. The challenge of managing COVID-19 associated pulmonary aspergillosis. Clin Infect Dis. 2020. 10.1093/cid/ciaa1211. - PMC - PubMed
    1. Koehler P, Salmanton-García J, Gräfe SK, Koehler FC, Mellinghoff SC, Seidel D, et al. Baseline predictors influencing the prognosis of invasive aspergillosis in adults. Mycoses. 2019;62:651–658. doi: 10.1111/myc.12926. - DOI - PubMed
    1. Campochiaro C, Della-Torre E, Cavalli G, De Luca G, Ripa M, Boffini N, et al. Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study. Eur J Intern Med. 2020;76:43–49. doi: 10.1016/j.ejim.2020.05.021. - DOI - PMC - PubMed

LinkOut - more resources